3,443 Shares in Cencora, Inc. $COR Purchased by Globeflex Capital L P

Globeflex Capital L P bought a new stake in Cencora, Inc. (NYSE:COR) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 3,443 shares of the company’s stock, valued at approximately $974,000.

A number of other institutional investors have also made changes to their positions in the stock. Kemnay Advisory Services Inc. purchased a new position in shares of Cencora during the 4th quarter worth approximately $25,000. Oakworth Capital Inc. purchased a new stake in Cencora in the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC purchased a new stake in Cencora in the fourth quarter valued at approximately $27,000. Elevation Wealth Partners LLC raised its position in Cencora by 506.2% in the second quarter. Elevation Wealth Partners LLC now owns 97 shares of the company’s stock valued at $27,000 after purchasing an additional 81 shares during the period. Finally, Archer Investment Corp lifted its stake in Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after purchasing an additional 47 shares in the last quarter. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Robert W. Baird set a $370.00 price target on Cencora in a research report on Thursday, August 6th. William Blair assumed coverage on Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating on the stock. Evercore reissued an “outperform” rating and set a $350.00 target price on shares of Cencora in a research note on Thursday, August 6th. UBS Group increased their target price on shares of Cencora from $412.00 to $430.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Finally, Wall Street Zen raised shares of Cencora from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Thirteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Cencora has a consensus rating of “Moderate Buy” and a consensus target price of $370.85.

Insiders Place Their Bets

In other Cencora news, Director Lauren M. Tyler purchased 550 shares of the business’s stock in a transaction on Monday, June 22nd. The shares were bought at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the purchase, the director directly owned 4,359 shares in the company, valued at approximately $1,177,932.57. This represents a 14.44% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.38% of the stock is currently owned by corporate insiders.

Cencora Stock Up 1.7%

Shares of NYSE:COR opened at $323.56 on Tuesday. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The firm’s 50 day moving average price is $303.43 and its 200 day moving average price is $311.25. The company has a quick ratio of 0.58, a current ratio of 0.93 and a debt-to-equity ratio of 3.53. The stock has a market cap of $61.75 billion, a price-to-earnings ratio of 24.04, a price-to-earnings-growth ratio of 1.83 and a beta of 0.57.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 EPS for the quarter, beating analysts’ consensus estimates of $4.35 by $0.13. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The company had revenue of $84.75 billion for the quarter, compared to the consensus estimate of $84.31 billion. During the same period in the prior year, the firm posted $4.00 EPS. The company’s quarterly revenue was up 5.1% compared to the same quarter last year. As a group, equities research analysts predict that Cencora, Inc. will post 17.87 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be issued a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, August 14th. Cencora’s dividend payout ratio is 17.83%.

Cencora announced that its board has authorized a stock repurchase program on Thursday, May 21st that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to reacquire up to 3.9% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.